0001654954-22-013526.txt : 20221007
0001654954-22-013526.hdr.sgml : 20221007
20221007170551
ACCESSION NUMBER: 0001654954-22-013526
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221006
FILED AS OF DATE: 20221007
DATE AS OF CHANGE: 20221007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Scott Kathleen D.
CENTRAL INDEX KEY: 0001794284
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40739
FILM NUMBER: 221301387
MAIL ADDRESS:
STREET 1: C/O CONATUS PHARMACEUTICALS INC.
STREET 2: 16745 WEST BERNARDO DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92127
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dermata Therapeutics, Inc.
CENTRAL INDEX KEY: 0001853816
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3525 DEL MAR HEIGHTS RD., #322
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858)-223-0882
MAIL ADDRESS:
STREET 1: 3525 DEL MAR HEIGHTS RD., #322
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
section16.xml
PRIMARY DOCUMENT
X0306
4
2022-10-06
0001853816
Dermata Therapeutics, Inc.
DRMA
0001794284
Scott Kathleen D.
3525 DEL MAR HEIGHTS RD.
#322
SAN DIEGO
CA
92130
true
Common Stock
2022-10-06
4
A
false
11359
0
A
27145
D
Common Stock
2439
I
By Scott 2008 Trust Dated 3/28/08
On October 6, 2022, the Reporting Person was granted 11,359 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.
/s/ Gerald T. Proehl, Attorney-in-Fact
2022-10-07